Investor mix
8 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 25% |
| Accelerator & incubator | 1 | 13% |
| Other / undisclosed | 5 | 63% |
Mucosal vaccines for the prevention and treatment of infectious diseases (specifically against respiratory tract pathogens)
8 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 25% |
| Accelerator & incubator | 1 | 13% |
| Other / undisclosed | 5 | 63% |